EA
STJ

Emerald Advisers’s St Jude Medical STJ Stock Holding History

Emerald Advisers’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-27,873
Closed -$1.53M – 340
2016
Q1 		$1.53M Buy
+27,873
New +$1.52M 0.07% 220

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Advisers's STJ Position: Q2 2016 in Review

Emerald Advisers sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 27,873 shares — an estimated $1.53M sold.

Emerald Advisers first reported a position in STJ in Q1 2016 and held it in 1 quarter. The position peaked at $1.53M in Q1 2016. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

  • Emerald Advisers reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
  • Emerald Advisers sold 27,873 St Jude Medical shares in Q2 2016, an estimated $1.53M.
  • Emerald Advisers first reported a position in St Jude Medical in Q1 2016 and held it in 1 quarter.
  • Emerald Advisers's St Jude Medical position peaked at $1.53M in Q1 2016.
  • 615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Emerald Advisers's 13F filing for Q2 2016, filed 28 Jul 2016.